In our paper [@B1], Figure [3](#F3){ref-type="fig"} should be corrected as follows.

The corrected figures do not affect the original conclusions of the findings.

![**High levels of KLB inhibit the proliferation and inhibits ERK, STAT3, AKT pathway of human NSCLC cells. A.** Cancer cells were transfected with a pCDH-KLB expression vector (KLB-OE) or a control pCDH vector (KLB-EV). IF staining of Ki67(red) and DAPI (for nucleus, blue) in HCC15 and H520 cells after transfection. Scale bar = 50 μm. The right panel was % of Ki-67 positive cells. **B.** Colony formation in SK-MES-1 and H520 cells. **C. (a)** Cell viability assay of stably overexpressed (KLB-OE) and control (KLB-EV) cancer cells. **(b)** Protein levels of KLB and proliferation marker PCNA were determined by western blot. **D.** qRT-PCR analysis of stemness-related genes in **(a)** SK-MES-1 cells and **(b)** H520 cells. E. Overexpression of KLB suppressed ERK, STAT3, AKT pathway. Data were represented as mean and SEM from three independent experiments. \* P \< 0.05. \*\* P \< 0.01. \*\*\* P \< 0.001.](thnov10p5528g001){#F3}
